Publications by authors named "Suzette Remillard"
Recurrent Ischemic Stroke and Bleeding in Patients With Atrial Fibrillation Who Suffered an Acute Stroke While on Treatment With Nonvitamin K Antagonist Oral Anticoagulants: The RENO-EXTEND Study.
Stroke
August 2022
Article Synopsis
- A study was conducted on patients with atrial fibrillation who had an ischemic stroke while using nonvitamin K antagonist oral anticoagulants to determine rates and risk factors for recurrent ischemic and bleeding events.
- Over an average follow-up of about 15 months, 15.5% of the 1,240 patients experienced 207 events, including ischemic strokes and major bleeding incidents, with specific risk factors identified for each type of event.
- The rates of ischemic and bleeding events did not significantly differ between patients who changed their anticoagulant treatment and those who continued with it.
Doctors learn different communication approaches for use during prevention consultations to promote healthy habits, so as to set up a partnership and to promote patient autonomy. Three of these approaches are shared decision making, when there is more than one reasonable choice, motivational interviewing, principally for behaviour change and therapeutic education, a pedagogical approach helping patients develop skills so that they may have a better management of their chronic illness. This article presents an overview of the commonalities and the differences between these approaches, often considered separately, nevertheless they are complementary and in practice, using elements of all three during a consultation could improve preventative care.
View Article and Find Full Text PDFStroke patient education: scientific evidence, practical application Stroke is a sudden and brutal event that changes every aspect of daily life. The patient and his family will need to develop skills in self-management of this chronic disease over the long term, managing risk factors, lifestyle changes and consequences of stroke. In recent years, randomized clinical trials have demonstrated the effectiveness of patient education and of several lifestyle-changing interventions adopted after a stroke.
View Article and Find Full Text PDFSex-related differences in risk factors, type of treatment received and outcomes in patients with atrial fibrillation and acute stroke: Results from the RAF-study (Early Recurrence and Cerebral Bleeding in Patients with Acute Ischemic Stroke and Atrial Fibrillation).
Eur Stroke J
March 2017
Article Synopsis
- Atrial fibrillation increases stroke risk, especially in women, who tend to have worse outcomes than men; this study assesses sex differences in stroke patients with atrial fibrillation regarding risk factors, treatments, and outcomes.
- Data from the RAF-study, involving 1029 patients, revealed women were younger and less likely to receive anticoagulant therapy both before and after stroke compared to men, despite similar timing for starting treatment.
- At 90 days post-stroke, more women were disabled or deceased (57.7%) compared to men (41.1%), highlighting a significant disparity in outcomes related to treatment patterns.
Article Synopsis
- - The study aimed to explore how the prestroke CHADS-VASc score, which assesses stroke risk in patients with atrial fibrillation (AF), relates to the severity of strokes and outcomes like disability and mortality after 90 days.
- - Researchers analyzed data from 1,020 patients with acute ischemic strokes and found that a higher prestroke CHADS-VASc score correlated with more severe strokes at admission and worse functional outcomes 90 days later.
- - The findings suggest that, for patients with AF, a high CHADS-VASc score not only indicates a greater stroke risk but is also linked to increased stroke severity and higher rates of disability and death after three months.
Anticoagulant therapy is recommended for the secondary prevention of stroke in patients with atrial fibrillation (AF). T he identification of patients at high risk for early recurrence, which are potential candidates to prompt anticoagulation, is crucial to justify the risk of bleeding associated with early anticoagulant treatment. The aim of this study was to evaluate in patients with acute ischemic stroke and AF the association between findings at trans-thoracic echocardiography (TTE) and 90 days recurrence.
View Article and Find Full Text PDFArticle Synopsis
- The study investigates the timing of anticoagulation therapy in patients with acute cardioembolic stroke and atrial fibrillation, focusing on risks for recurrent ischemic events and severe bleeding.
- Out of 1029 patients, 12.6% experienced adverse events within 90 days, with factors like CHA2DS2-VASc score and type of anticoagulant affecting outcomes.
- Starting anticoagulants 4 to 14 days after stroke onset is linked to a significant reduction in complications compared to starting before 4 days or after 14 days.